Patents Assigned to Mirimus, Inc.
  • Compositions and methods of generating novel amiRNA
    Patent number: 12365902
    Abstract: Provided herein are Compositions and Methods of Generating Novel amiRNA's. Provided herein are methods for producing or generating one or more amiRNAs; also provided are constructs and compositions useful in the methods. The methods and constructs provided in this disclosure are highly efficient methods for production of a new generation of amiRNAs.
    Type: Grant
    Filed: September 27, 2024
    Date of Patent: July 22, 2025
    Assignee: Mirimus, Inc.
    Inventors: Giuseppe Militello, Christof Fellmann, Johannes Zuber
  • Methods of genetic mediated engineering of RNAi models
    Patent number: 11957114
    Abstract: Provided herein are systems and methods for Inducible and conditional CRISPR/Cas9 and RNAi. From animal model creation and the efficiency of CRISPR-based targeting, the present invention comprises developing RNAi models that enable inducible and reversible gene silencing to simulate new therapeutic regimes.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: April 16, 2024
    Assignee: Mirimus, Inc.
    Inventor: Prem Premsrirut
  • METHODS OF GENETIC MEDIATED ENGINEERING OF RNAi MODELS
    Publication number: 20210259218
    Abstract: Provided herein are systems and methods for Inducible and conditional CRISPR/Cas9 and RNAi. From animal model creation and the efficiency of CRISPR-based targeting, the present invention comprises developing RNAi models that enable inducible and reversible gene silencing to simulate new therapeutic regimes.
    Type: Application
    Filed: November 28, 2018
    Publication date: August 26, 2021
    Applicant: Mirimus, Inc.
    Inventor: Prem PREMSRIRUT